Development and validation of a recombinant human TNF-α based ELISA to detect and quantify adalimumab.
- DOI
- 10.1016/j.bbrep.2025.102005
- Published
- 2025 Jun
- Container
- Biochemistry and biophysics reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bbrep.2025.102005,
title = {Development and validation of a recombinant human TNF-α based ELISA to detect and quantify adalimumab.},
author = {Saini DK and Devaramani MS and Shanmugavel H and Tabassum SZ and Mudnakudu-Nagaraju KK and Siddesha JM and Shetty R},
year = {2025},
journal = {Biochemistry and biophysics reports},
doi = {10.1016/j.bbrep.2025.102005},
url = {https://doi.org/10.1016/j.bbrep.2025.102005}
}RIS
TY - JOUR TI - Development and validation of a recombinant human TNF-α based ELISA to detect and quantify adalimumab. AU - Saini DK AU - Devaramani MS AU - Shanmugavel H AU - Tabassum SZ AU - Mudnakudu-Nagaraju KK AU - Siddesha JM AU - Shetty R PY - 2025 JO - Biochemistry and biophysics reports DO - 10.1016/j.bbrep.2025.102005 UR - https://doi.org/10.1016/j.bbrep.2025.102005 ER -
APA
DK, S., MS, D., H, S., SZ, T., KK, M., JM, S., & R, S. (2025). Development and validation of a recombinant human TNF-α based ELISA to detect and quantify adalimumab.. Biochemistry and biophysics reports. https://doi.org/10.1016/j.bbrep.2025.102005
Source records
- pubmed · retrieved 2026-09-25T05:04:45.692Z